Online citations, reference lists, and bibliographies.

Intranasal Piperine-Loaded Chitosan Nanoparticles As Brain-Targeted Therapy In Alzheimer's Disease: Optimization, Biological Efficacy, And Potential Toxicity.

Y. Elnaggar, Samar M. Etman, D. Abdelmonsif, O. Abdallah
Published 2015 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Piperine (PIP) is a phytopharmaceutical with reported neuroprotective potential in Alzheimer's disease (AD). Oral PIP delivery suffers from its hydrophobicity and pre-systemic metabolism. In this article, mono-disperse intranasal chitosan nanoparticles (CS-NPs) were elaborated for brain targeting of PIP. Formula optimization was based on particle size (PS), zeta potential (ZP), polydispersity index (PDI), % entrapment efficiency (% EE), release studies, and transmission electron microscopy. AD was induced in 48 male Wistar rats on which full behavioral and biochemical testing was conducted. Brain toxicity was assessed based on Caspase-3 assay for apoptosis and tumor necrosis factor for inflammation. Spherical NPs with optimum % EE (81.70), PS (248.50 nm), PDI (0.24), and ZP (+56.30 mV) were elaborated. PIP-NPs could significantly improve cognitive functions as efficient as standard drug (donpezil injection) with additional advantages of dual mechanism (Ach esterase inhibition and antioxidant effect). CS-NPs could significantly alleviate PIP nasal irritation and showed no brain toxicity. This work was the first to report additional mechanism of PIP in AD via anti-apoptosis and anti-inflammatory effects. To conclude, mucoadhesive CS-NPs were successfully tailored for effective, safe, and non-invasive PIP delivery with 20-folds decrease in oral dose, opening a gate for a future with lower AD morbidity.
This paper references
Total Antioxidant Capacity: a biomarker in biomedical and nutritional studies
C. Kusano (2008)
10.22203/ECM.V024A10
Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation.
M. Oliveira (2012)
10.1016/J.IJPHARM.2007.03.025
Intranasal delivery: physicochemical and therapeutic aspects.
H. R. Costantino (2007)
10.1038/sj.npp.1301259
Preclinical Investigation of the Functional Effects of Memantine and Memantine Combined with Galantamine or Donepezil
D. Woodruff-Pak (2007)
10.1023/A:1018901302450
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
10.1002/(SICI)1099-1263(199705)17:3<189::AID-JAT431>3.0.CO;2-7
Interaction of Exercise Training and Chronic Ethanol Ingestion on Hepatic and Plasma Antioxidant System in Rat
K. Husain (1997)
10.1016/j.ejps.2012.12.007
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Shadab Md (2013)
10.1038/aps.2011.209
Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model
Li-hua Lai (2012)
10.1016/S0165-0173(01)00067-4
Applications of the Morris water maze in the study of learning and memory
R. D'Hooge (2001)
10.1037//0735-7044.103.2.319
Effects of intrahippocampal administration of colchicine on incentive contrast and on radial maze performance.
C. Flaherty (1989)
10.1016/S0091-3057(02)00838-9
Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats
M. Kumar (2002)
10.1016/j.jconrel.2014.02.004
Lecithin-based nanostructured gels for skin delivery: an update on state of art and recent applications.
Y. S. Elnaggar (2014)
Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists.
R. D'hooge (1996)
10.1016/J.IJPHARM.2005.03.027
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor.
Y. Aktaş (2005)
10.1021/am900665z
Electrostatic interactions are not sufficient to account for chitosan bioactivity.
A. Pavinatto (2010)
10.1016/j.ijpharm.2013.06.039
Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
May S. Freag (2013)
Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type.
A. Kumar (2007)
10.4161/HV.27449
Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
A. Smith (2014)
10.1016/j.ijpharm.2015.03.052
Novel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: Development, in-vitro appraisal and in-vivo studies.
Wessam M. El‐Refaie (2015)
10.1084/jem.183.5.1957
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death
L. Casciola-Rosen (1996)
10.1016/J.JCONREL.2005.11.014
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
M. Amidi (2006)
10.1016/0006-2952(61)90145-9
A new and rapid colorimetric determination of acetylcholinesterase activity.
G. Ellman (1961)
10.1001/ARCHNEUR.60.8.1119
Alzheimer disease in the US population: prevalence estimates using the 2000 census.
L. Hebert (2003)
10.1016/S0168-3659(99)00150-9
Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery.
K. Nakamura (1999)
10.2147/IJN.S25825
Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles
Y. S. Elnaggar (2011)
10.1042/bj0990667
Mechanisms of lipid peroxide formation in animal tissues.
E. D. Wills (1966)
10.1016/j.ijbiomac.2013.04.024
Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety.
K. Nagpal (2013)
10.1201/9781420041811.ch10
Spatial navigation (water maze) tasks
Jr. Alvin V. Terry (2009)
10.4236/ABB.2011.22017
Antidepressant and cognitive activities of intranasal piperine-encapsulated liposomes
Aroonsri Priprem (2011)
10.1016/J.EJPHAR.2006.08.076
Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.
A. Kumar (2006)
10.2147/IJN.S80055
Summary of the National Conference on Challenges in Biomaterials Research jointly organized by VIT and CSIR-CECRI
Geetha Manivasagam (2015)
10.1073/pnas.86.20.8152
Hypothesis: microtubules, a key to Alzheimer disease.
S. Matsuyama (1989)
10.2147/IJN.S33186
Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal
M. A. Elsheikh (2012)
10.1504/IJNT.2011.041443
Sildenafil citrate nanoemulsion vs. self-nanoemulsifying delivery systems: rational development and transdermal permeation
Yosra S.R. Elnaggar (2011)
10.1016/j.ejps.2012.01.002
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
X. Zhang (2012)
Local and systemic safety of intranasal corticosteroids.
J. Sastre (2012)
10.1016/S0165-0173(97)00016-7
Cholinergic activity and amyloid precursor protein metabolism
M. R. Roberson (1997)
10.3109/1061186X.2012.747529
Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model
Mohammad Yusuf (2013)
10.1016/j.jconrel.2014.08.019
Rationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriers.
Manal A Elsheikh (2014)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1002/cne.1393
Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus
Z. Liu (2001)
10.2174/2211738511301020005
Intranasal Fluorescent Nanocrystals for Longitudinal In Vivo Evaluation of Cerebral Microlesions
Angela O. Choi (2013)
10.1016/j.ijpharm.2009.06.019
Nanoparticles for direct nose-to-brain delivery of drugs.
Alpesh Mistry (2009)
10.1016/0003-9861(78)90479-4
Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.
Y. Kono (1978)
10.1016/j.fct.2008.06.014
Piperine, the potential functional food for mood and cognitive disorders.
J. Wattanathorn (2008)
10.1016/S0166-4328(02)00272-3
Glutamate receptor function in learning and memory
G. Riedel (2003)
10.1248/CPB.53.832
Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity.
S. A. Lee (2005)
10.1007/s11920-012-0288-5
Behavioral Disturbance in Dementia
A. Desai (2012)
10.1016/S0006-8993(02)03152-9
Impaired axonal transport of cortical neurons in Alzheimer’s disease is associated with neuropathological changes
Jiapei Dai (2002)
Biostatistics 102: quantitative data--parametric & non-parametric tests.
Chan Yh (2003)
10.4061/2009/972178
Neuroprotective Effects of Centella asiatica against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress
Anil Kumar (2009)
10.1081/DDC-120018377
Preparation and Characterization of Chitosan Microspheres Containing Doxifluridine
T. Yoshino (2003)
Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
V. Calabrese (2003)
10.1111/j.1471-4159.2011.07236.x
Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain.
V. Tiwari (2011)
10.1196/ANNALS.1331.025
Vitamin E in neurodegenerative disorders: Alzheimer's disease.
Kanatol Kontush (2004)
10.1038/jid.2012.399
Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens
A. Friedman (2013)
10.1016/j.neuron.2006.08.005
Mice Deficient for the Vesicular Acetylcholine Transporter Are Myasthenic and Have Deficits in Object and Social Recognition
V. Prado (2006)
10.1007/12_2011_117
Chitosan and Its Derivatives for Drug Delivery Perspective
C. P. Sharma (2011)
10.3109/1061186X.2012.725405
Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration
S. R. K. Vaka (2013)
10.1006/PHRS.1999.0640
Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination.
S. Gupta (2000)
10.1016/S0378-5173(02)00548-3
Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles.
Y. Xu (2003)
10.1016/j.jnutbio.2012.03.018
Anti-apoptotic and anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson's rat model.
Pallavi Shrivastava (2013)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
Protein measurement with the Folin phenol reagent.
O. H. Lowry (1951)
10.1002/14651858.CD000202
Tacrine for Alzheimer's disease.
N. Qizilbash (2000)
10.1016/j.ejpb.2008.07.005
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Xiaomei Wang (2008)
10.3109/10611860903483396
Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses
Abeer M. Al-Ghananeem (2010)
10.1089/ars.2010.3208
Reactive oxygen species in the regulation of synaptic plasticity and memory.
C. A. Massaad (2011)
10.1136/jcp.54.5.356
Method for the measurement of antioxidant activity in human fluids
D. Koraćević (2001)
10.1007/s11095-015-1672-8
Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation
Wessam M. El‐Refaie (2015)
10.1016/j.jalz.2012.11.007
The global prevalence of dementia: A systematic review and metaanalysis
M. Prince (2013)
10.1016/j.fct.2009.12.009
Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease.
Pennapa Chonpathompikunlert (2010)
10.1124/pr.57.2.4
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
B. Hawkins (2005)
10.1081/IPH-200026887
Inhibitory Effect of Water‐Soluble Chitosan on TNF‐α and IL‐8 Secretion from HMC‐1 Cells
M. Kim (2004)
10.5555/uri:pii:002221439290284R
Free radicals, antioxidants, and human disease: where are we now?
B. Halliwell (1992)
10.1211/0022357022539
Is nose-to-brain transport of drugs in man a reality?
L. Illum (2004)
10.1016/S0531-5565(00)00156-X
Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update
S. Hoyer (2000)
10.2147/IJN.S45231
Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation
May S. Freag (2013)
10.1371/journal.pone.0061052
Suppression of Neuroinflammatory and Apoptotic Signaling Cascade by Curcumin Alone and in Combination with Piperine in Rat Model of Olfactory Bulbectomy Induced Depression
P. Rinwa (2013)
10.1016/j.ejps.2012.04.013
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
M. Fazil (2012)
Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera.
R. Ganguly (2008)



This paper is referenced by
10.3389/fbioe.2020.00238
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Seyed Zachariah Moradi (2020)
10.1016/j.ijbiomac.2020.01.070
Surface functionalization of chitosan with 5-nitroisatin.
Marjan Nasrabadi (2020)
10.1080/10717544.2018.1428243
Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease
Govindarajan Karthivashan (2018)
10.1007/978-3-319-63633-7_6
Nanoformulations for Therapeutics
P S Srinivasa Rao (2017)
10.3390/pharmaceutics12010070
Effective Targeting of Colon Cancer Cells with Piperine Natural Anticancer Prodrug Using Functionalized Clusters of Hydroxyapatite Nanoparticles
K. AbouAitah (2020)
10.3389/fphar.2018.00549
Comparative Evaluation of Prosopis cineraria (L.) Druce and Its ZnO Nanoparticles on Scopolamine Induced Amnesia
Ekta Yadav (2018)
10.2174/1872211313666190516095309
Application of Optimization Technique to Develop Nano-Based Carrier of Nigella sativa Essential Oil: Characterization and Assessment
A. M. Dawaba (2019)
10.1080/17425255.2018.1418854
Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives
Sang Hoon Lee (2018)
10.1208/s12249-018-1180-3
Oral Brain-Targeted Microemulsion for Enhanced Piperine Delivery in Alzheimer’s Disease Therapy: In Vitro Appraisal, In Vivo Activity, and Nanotoxicity
Samar M. Etman (2018)
10.1038/srep29753
Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice
Chuanlong Guo (2016)
10.1016/j.ijbiomac.2019.12.177
Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer.
Samar M. Etman (2019)
10.2174/1381612826666200115101544
Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders.
Joana Bicker (2020)
10.1111/jphp.13132
Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Seetha Harilal (2019)
10.2174/0929867326666190827151741
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
Areen Alshweiat (2019)
10.1080/10717544.2019.1636420
Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease
Shengnan Tang (2019)
10.15406/japlr.2018.07.00271
Chitosan-based nanomaterials on controlled bioactive agents delivery: a review
Cristóbal José Lárez Velásquez (2018)
10.3390/md15110322
Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer’s Disease
Qian-Qian Ouyang (2017)
10.1016/bs.irn.2016.06.002
Application of Nanomedicine to the CNS Diseases.
D. Carradori (2016)
10.1016/j.eurpolymj.2020.109607
Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders
Ramin Ansari (2020)
10.1016/j.jddst.2020.101636
Progress and perspectives on nanoplatforms for drug delivery to the brain
Yingqian Xu (2020)
10.1016/j.ijpharm.2020.119097
Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer.
Samar M. Etman (2020)
10.1007/978-981-15-1664-1_8
Nutraceutical-Loaded Chitosan Nanoparticles for Healthcare Applications
Entesar Hanan (2020)
10.2147/DDDT.S97982
Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres
Lu Shan (2016)
10.1186/s13024-018-0236-x
Piperine ameliorates SCA17 neuropathology by reducing ER stress
Jifeng Guo (2018)
10.1080/10837450.2019.1631846
Intranasal Tadalafil nanoemulsions: formulation, characterization and pharmacodynamic evaluation
Bassant Elbardisy (2019)
10.1021/acs.biomac.7b00877
Targeting of Cellular Organelles by Fluorescent Plasmid DNA Nanoparticles.
Diana Costa (2017)
10.1016/j.jconrel.2018.05.011
Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs
Mukta Agrawal (2018)
10.2147/IJN.S151475
Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects
Xiuju Yan (2018)
10.1016/j.jconrel.2016.10.013
Design and fabrication of hydrogel-based nanoparticulate systems for in vivo drug delivery.
W. Lai (2016)
10.1080/17425255.2019.1672658
Role of piperine in CNS diseases: pharmacodynamics, pharmacokinetics and drug interactions
Tianjing Ren (2019)
10.1016/bs.apcsb.2017.02.001
Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
Yousef Sawikr (2017)
10.1016/j.nano.2020.102149
Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and Nanotherapy.
H. Derakhshankhah (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar